Leading the Future of Epigenetics
Leading the Future of Epigenetics
Revolutionizing
Epigenetic
Research
Productivity
Studies
Research
Research
Productivity
Studies
Research
At Epigenica, we build innovative products for epigenetic analysis that foster scientific breakthroughs to advance human health.
Quntative epigenomic maps
High-throughput Analysis
Comprehensive Profiling
The EpiFinder Platform
The EpiFinder Platform
Our EpiFinder™ platform is a first-in-class multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks that lets scientists explore epigenetic biomarkers with unprecedented speed, scalability, and affordability. Powered by our patented hmqChIP-seq technology, the EpiFinder™ platform overcomes barriers to epigenetics research, by allowing for high throughput and multiplexing, as well as another benefits.
Quantitative epigenomic maps
Quantitative epigenomic maps
Quantitative epigenomic maps
Ability to combine DNAm and HPTM for a streamlined workflow
Ability to combine DNAm and HPTM for a streamlined workflow
Ability to combine DNAm and HPTM for a streamlined workflow
Low amounts of input material
Low amounts of input material
Low amounts of input material
Optimized to work with an array of starting materials
Optimized to work with an array of starting materials
Optimized to work with an array of starting materials
EpiFinder Genome
EpiFinder Genome
EpiFinder Genome
A Breakthrough in Epigenetic Profiling
The flagship product in our EpiFinder™ product family, EpiFinder™ Genome for comprehensive genome-wide epigenomic profiling, enables researchers to simultaneously target up to 8 epigenetic markers in up to 24 samples, including replicates. The ability to include numerous conditions and replicates in a single workflow greatly increases the robustness of and confidence in the results. EpiFinder Genome is compatible with cultured and primary cells, as well as tissue. Generating 192 quantitative genome-wide profiles – equivalent to running 192 parallel ChIP-seq experiments, in a fraction of the time – , EpiFinder™ Genome brings in-depth insights for biomedical research, drug discovery and development, and precision medicine.
A Breakthrough in Epigenetic Profiling
The flagship product in our EpiFinder™ product family, EpiFinder™ Genome for comprehensive genome-wide epigenomic profiling, enables researchers to simultaneously target up to 8 epigenetic markers in up to 24 samples, including replicates. The ability to include numerous conditions and replicates in a single workflow greatly increases the robustness of and confidence in the results. EpiFinder Genome is compatible with cultured and primary cells, as well as tissue. Generating 192 quantitative genome-wide profiles – equivalent to running 192 parallel ChIP-seq experiments, in a fraction of the time – , EpiFinder™ Genome brings in-depth insights for biomedical research, drug discovery and development, and precision medicine.
A Breakthrough in Epigenetic Profiling
The flagship product in our EpiFinder™ product family, EpiFinder™ Genome for comprehensive genome-wide epigenomic profiling, enables researchers to simultaneously target up to 8 epigenetic markers in up to 24 samples, including replicates. The ability to include numerous conditions and replicates in a single workflow greatly increases the robustness of and confidence in the results. EpiFinder Genome is compatible with cultured and primary cells, as well as tissue. Generating 192 quantitative genome-wide profiles – equivalent to running 192 parallel ChIP-seq experiments, in a fraction of the time – , EpiFinder™ Genome brings in-depth insights for biomedical research, drug discovery and development, and precision medicine.
Easy to use
Flexible membership plans that cater to different needs, whether you need a desk for a day or an office for a year.
Easy to use
Flexible membership plans that cater to different needs, whether you need a desk for a day or an office for a year.
High throughput
Co-working spaces eliminate the overhead costs associated with traditional office spaces, such as utilities and maintenance.
High throughput
Co-working spaces eliminate the overhead costs associated with traditional office spaces, such as utilities and maintenance.
Easy to use
Flexible membership plans that cater to different needs, whether you need a desk for a day or an office for a year.
High throughput
Co-working spaces eliminate the overhead costs associated with traditional office spaces, such as utilities and maintenance.
Quantitative epigenomic maps
A wide range of amenities including high-speed internet, printing services, and complimentary refreshments.
Quantitative epigenomic maps
A wide range of amenities including high-speed internet, printing services, and complimentary refreshments.
Quantitative epigenomic maps
A wide range of amenities including high-speed internet, printing services, and complimentary refreshments.
Combining DNAm and HPTM
A wide range of amenities including high-speed internet, printing services, and complimentary refreshments.
Combining DNAm and HPTM
A wide range of amenities including high-speed internet, printing services, and complimentary refreshments.
Low amounts of input material
Spaces designed to promote a healthy work-life balance, including wellness rooms and social events.
Low amounts of input material
Spaces designed to promote a healthy work-life balance, including wellness rooms and social events.
Combining DNAm and HPTM
A wide range of amenities including high-speed internet, printing services, and complimentary refreshments.
Low amounts of input material
Spaces designed to promote a healthy work-life balance, including wellness rooms and social events.
quantitative ChIP-seq tracks
quantitative ChIP-seq tracks
quantitative ChIP-seq tracks
≤
samples
≤
samples
≤
samples
The Problem
The Problem
The Problem
Barriers to Epigenetic Research
Barriers to Epigenetic Research
Barriers to Epigenetic Research
Current commercial epigenomics technologies are limited by their ability to profile one or a few marks and samples at a time, at low throughput and high cost. Today, researchers can screen for either DNA methylation (DNAm) or histone post-translational modifications (HPTMs) – but not both simultaneously. Experiments also require many cells to generate accurate information. Considerable input material is needed to undertake comprehensive, epigenetic screens across multiple samples and multiple epigenetic markers, Because it’s difficult to make quantitative comparisons across studies or samples, the utility of epigenetic research is limited.
Current commercial epigenomics technologies are limited by their ability to profile one or a few marks and samples at a time, at low throughput and high cost. Today, researchers can screen for either DNA methylation (DNAm) or histone post-translational modifications (HPTMs) – but not both simultaneously. Experiments also require many cells to generate accurate information. Considerable input material is needed to undertake comprehensive, epigenetic screens across multiple samples and multiple epigenetic markers, Because it’s difficult to make quantitative comparisons across studies or samples, the utility of epigenetic research is limited.
Articles and insights
Articles and insights
Articles and insights
